Brookline, MA, United States of America

Shi Yin Foo

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shi Yin Foo

Introduction

Shi Yin Foo is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of peripheral arterial disease and contrast-induced nephropathy. With a total of 2 patents, her work reflects a commitment to advancing healthcare solutions.

Latest Patents

One of her latest patents focuses on the use of IL-1β binding antibodies for treating peripheral arterial disease. This invention outlines a method for alleviating the symptoms of this condition by administering a specific dosage of the antibody. Another notable patent involves a method for treating contrast-induced nephropathy, which includes the use of a neutral endopeptidase inhibitor. This invention also details a combination of pharmacologically active agents aimed at preventing this condition.

Career Highlights

Shi Yin Foo is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to leverage her expertise in developing innovative treatments that address critical health issues.

Collaborations

Throughout her career, Shi Yin Foo has collaborated with esteemed colleagues such as Craig Basson and Mark C Fishman. These partnerships have further enhanced her research and development efforts in the medical field.

Conclusion

Shi Yin Foo's contributions to medical innovation are noteworthy, particularly in the areas of peripheral arterial disease and contrast-induced nephropathy. Her patents and collaborations reflect her dedication to improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…